Trial updateGlaucoma
Nicotinamide for Retinal Protection in Primary Open-Angle Glaucoma (NADIR Trial)
Not yet recruiting. Phase 2. Registered enrolment: 96. University of Chicago
Why it matters
Track this study through NCT07808333. No results are posted in this registry record.
The study at a glance
- Registry status
- Not yet recruiting
- Phase
- Phase 2
- Registered enrolment
- 96
- Results posted
- No
- Sponsor
- University of Chicago
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.